search
Back to results

Pulmonary Rehabilitation in Asthmatic Patient

Primary Purpose

Asthmatic, Children

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Intervention Group
Control Group
Sponsored by
Fernanda de Cordoba Lanza
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthmatic focused on measuring Pulmonary rehabilitation, Asthma, Children, Teenager, Physical capacity

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • between six and 18 years old
  • asthma-diagnosed patients
  • under medical treatment and disease control

Exclusion Criteria:

  • fail to carry out the protocol evaluations
  • interrupt the medical care and/or drug-based treatment
  • acute lung infection or other chronic lung diseases
  • other comorbidities (neuropathies, heart disease)
  • missing in more than 20% the rehabilitation protocol

Sites / Locations

  • Fernanda C Lanza

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention Group

Control Group

Arm Description

The intervention group will have supervised rehabilitation program held twice a week, each session will have 60 minutes duration, with minimum interval of 24 hours, for a period of 8 weeks. Each session will consist of three parts: aerobic training, strength training and respiratory physiotherapy. The aerobic training will be held for 35 minutes (10 min of warm up, 20 min on target load and 5 min of slowdown) with initial intensity of 60% of the maximum load obtained in the maximal cardiopulmonary exercise testing or in incremental shuttle walk test (ISWT). The intensity will be gradually increased up to 80%, so that fatigue or dyspnea values are kept between 4 and 6, according to the modified Borg scale.

The control group will be subjected to supervised respiratory physiotherapy and stretching exercises twice a week, each session with duration of 60 minutes, with minimum interval of 24 hours, for a period of 8 weeks. The oral high-frequency oscillation device (Flutter®) will be used for 10 minutes, 5 minutes in each lateral decubitus, followed by the stretching of upper and lower limbs for 40 minutes. All exercises will be active, performed in sitting and lying positions without increasing the heart rate. The remaining 10 minutes will be used to discuss doubts about the disease and the use of the booklet.

Outcomes

Primary Outcome Measures

Physical capacity as measure by distance walked of shuttle walk test and oxygen consumption (VO2)
Modified shuttle test was conducted

Secondary Outcome Measures

Muscle strength as measure by electromyography (EMG)
1 maximal repetition was performed
Muscle endurance as measure by electromyography (EMG)
Quality of life measured by Pediatric questionnaire
Inflammatory markers as measure by interleukines

Full Information

First Posted
February 10, 2015
Last Updated
August 5, 2019
Sponsor
Fernanda de Cordoba Lanza
Collaborators
University of Nove de Julho, Fundação de Amparo à Pesquisa do Estado de São Paulo, Federal University of Minas Gerais
search

1. Study Identification

Unique Protocol Identification Number
NCT02383069
Brief Title
Pulmonary Rehabilitation in Asthmatic Patient
Official Title
Pulmonary Rehabilitation in Asthmatic Pediatric Patients: Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
February 2015 (Actual)
Primary Completion Date
July 2016 (Actual)
Study Completion Date
August 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Fernanda de Cordoba Lanza
Collaborators
University of Nove de Julho, Fundação de Amparo à Pesquisa do Estado de São Paulo, Federal University of Minas Gerais

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Asthma is one of the main chronic diseases in childhood and it is characterized by the inflammation of airways. Individuals with chronic lung disease are more susceptible to present reduction in exercise tolerance due to pulmonary limitations. The pulmonary rehabilitation may improve the physical capacity in asthmatic patients, as observed in other chronic lung diseases.
Detailed Description
The asthmatic patient's clinical changes may impair their functional capacity and exercise tolerance. Thus, the treatment of these individuals should be extended to pulmonary rehabilitation. Randomized clinical trials have shown interesting results, whether in cardiopulmonary conditions, quality of life or in the number of crises, after applying pulmonary rehabilitation program in asthmatic children and adolescents. In a systematic review on physical training with asthmatic children and adolescents the authors concluded that physical activity should be recommended to this population, although some issues have not yet been clarified due to limitations in the clinical trial. The control of the disease has not been evaluated by specific questionnaires in any study. The assessment of inflammatory markers was rarely addressed and the same occurred in the quality of life after physical training. In addition, it is possible to question the intensity and frequency of training, factors that can significantly contribute to the intervention results. All these information let us know that is necessary a randomized control trial to answer questions about physical characteristics, quality of life, inflammatory markers, and muscles strength.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthmatic, Children
Keywords
Pulmonary rehabilitation, Asthma, Children, Teenager, Physical capacity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
66 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
The intervention group will have supervised rehabilitation program held twice a week, each session will have 60 minutes duration, with minimum interval of 24 hours, for a period of 8 weeks. Each session will consist of three parts: aerobic training, strength training and respiratory physiotherapy. The aerobic training will be held for 35 minutes (10 min of warm up, 20 min on target load and 5 min of slowdown) with initial intensity of 60% of the maximum load obtained in the maximal cardiopulmonary exercise testing or in incremental shuttle walk test (ISWT). The intensity will be gradually increased up to 80%, so that fatigue or dyspnea values are kept between 4 and 6, according to the modified Borg scale.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
The control group will be subjected to supervised respiratory physiotherapy and stretching exercises twice a week, each session with duration of 60 minutes, with minimum interval of 24 hours, for a period of 8 weeks. The oral high-frequency oscillation device (Flutter®) will be used for 10 minutes, 5 minutes in each lateral decubitus, followed by the stretching of upper and lower limbs for 40 minutes. All exercises will be active, performed in sitting and lying positions without increasing the heart rate. The remaining 10 minutes will be used to discuss doubts about the disease and the use of the booklet.
Intervention Type
Other
Intervention Name(s)
Intervention Group
Other Intervention Name(s)
Pulmonary Rehabilitation
Intervention Description
Aerobic training
Intervention Type
Other
Intervention Name(s)
Control Group
Other Intervention Name(s)
Chest Physiotherapy
Intervention Description
Chest physiotherapy: Flutter and muscle stretching
Primary Outcome Measure Information:
Title
Physical capacity as measure by distance walked of shuttle walk test and oxygen consumption (VO2)
Description
Modified shuttle test was conducted
Time Frame
Physiscal capacity will be measured at the beginning and at the end of the protocol (after 8 weeks)
Secondary Outcome Measure Information:
Title
Muscle strength as measure by electromyography (EMG)
Description
1 maximal repetition was performed
Time Frame
Muscles strenght will be measured at the begening and at the end of the protocol (after 8 weeks).
Title
Muscle endurance as measure by electromyography (EMG)
Time Frame
Muscles endurance will be measured at the begening and at the end of the protocol (after 8 weeks).
Title
Quality of life measured by Pediatric questionnaire
Time Frame
Quesitionnaire will be measured at the begening and at the end of the protocol (after 8 weeks).
Title
Inflammatory markers as measure by interleukines
Time Frame
Inflamatory markers will be measured at the begening and at the end of the protocol (after 8 weeks).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: between six and 18 years old asthma-diagnosed patients under medical treatment and disease control Exclusion Criteria: fail to carry out the protocol evaluations interrupt the medical care and/or drug-based treatment acute lung infection or other chronic lung diseases other comorbidities (neuropathies, heart disease) missing in more than 20% the rehabilitation protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dirceu Solé, PhD
Organizational Affiliation
Unifesp, Federal University of Sao Paulo
Official's Role
Study Chair
Facility Information:
Facility Name
Fernanda C Lanza
City
Sao Paulo
ZIP/Postal Code
01504001
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33607978
Citation
Silva EP, Soares BA, Reimberg MM, Ritti-Dias R, Nascimento KS, Anjos FS, Wandalsen GF, Sole D, Dal Corso S, Lanza FC. Heart rate recovery in asthmastic children and adolescents after clinical field test. BMC Pulm Med. 2021 Feb 19;21(1):61. doi: 10.1186/s12890-020-01355-9.
Results Reference
derived
PubMed Identifier
26268930
Citation
Reimberg MM, Castro RA, Selman JP, Meneses AS, Politti F, Mallozi MC, Wandalsen GF, Sole D, De Angelis K, Dal Corso S, Lanza FC. Effects of a pulmonary rehabilitation program on physical capacity, peripheral muscle function and inflammatory markers in asthmatic children and adolescents: study protocol for a randomized controlled trial. Trials. 2015 Aug 13;16:346. doi: 10.1186/s13063-015-0876-x.
Results Reference
derived

Learn more about this trial

Pulmonary Rehabilitation in Asthmatic Patient

We'll reach out to this number within 24 hrs